Search Results 1211-1220 of 19399 for Hemoglobin

1. Sorafenib for Hepatopulmonary Syndrome - Mayo Clinic

   Presence of cirrhosis/hepatic fibrosis and/or portal hypertension. Child-Pugh class A or B liver disease; Platelet count ≥ 30 ×10e9 per liter; Hemoglobin ≥ ...

2. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   - Hemoglobin >= 8.0 g/dL (=< 28 days prior to registration) - Without growth factor support, blood transfusion, or platelet stimulating agents for the past ...

3. Study of Determine the Safety and Effectiveness of SHP647 as Maintenance Therapy in Subjects with Moderate-to-Severe Crohn's Disease - Mayo Clinic

   Hemoglobin level ≤ 80 g/L (8.0 g/dL);; Platelet count ≤ 100 × 109/L (100,000 cells/mm^3) or ≥ 1000 × 109/L (1,000,000 cells/mm^3)*;; White blood cell count ...

4. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

   Hemoglobin ≥10 g/dl. Total bilirubin level ≤1.5 × ULN. Creatinine ≤1.5 x ULN or creatinine clearance >60 mL/min/1.73 m2 for patients with creatinine ...

5. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 - Mayo Clinic

   Able to swallow whole capsules [Pending availability of granule formulation]. 6. Hematologic Function: Absolute neutrophil count ≥ 1200/µL, hemoglobin ≥ 9g/dL ...

6. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/deciliter; Serum Creatinine ≤ 1.5 x ULN or creatinine clearance > 40ml/min using the Cockcroft-Gault formula. Female CrCl = (140 - age ...

7. A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread - Mayo Clinic

   Participation eligibility · Hematologic: Absolute neutrophil count (ANC) ≥1.5 x 10^9/liter (L), platelets ≥ 100 x 10^9/L, and hemoglobin ≥ 8 gram/deciliter (g ...

8. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; subjects with hemoglobin ≥ 8-9 g/dL may be included with approval from the Medical Monitor;; In subjects transfused before study entry ...

9. Hyperbaric oxygen therapy - Mayo Clinic

   This type of therapy is a well-known treatment for decompression sickness, but it has other uses. Find out about why and how oxygen may help heal the body.

10. Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects with Neuroendocrine Tumors - Mayo Clinic

    Hemoglobin ≥9 mg/dL. Creatinine <1.5 X upper limit of normal or estimated plasma creatinine clearance of ≥40 mL/min. Signed informed consent form; Recovered ...